Turing Pharmaceuticals, the
company that drew widespread
condemnation two months ago
when it bought the toxoplasmosis
drug pyrimethamine (Daraprim)
and raised the price by over 5000%,
has reneged on its promise to
lower the drug’s price by Christmas,
instead choosing to drop the price
charged to hospitals and enhancing
support to disadvantaged patients.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Dec 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.